Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-20
2008-09-30
McKane, Joseph (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S307400
Reexamination Certificate
active
07429608
ABSTRACT:
Substituted benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
REFERENCES:
patent: 2004/0087626 (2004-05-01), Renhowe et al.
patent: 2004/0122237 (2004-06-01), Amiri et al.
patent: 2164661 (1973-07-01), None
patent: 0 419 210 (1991-03-01), None
patent: WO 02/46169 (2002-06-01), None
patent: WO 03/051277 (2003-06-01), None
patent: WO 03/053939 (2003-07-01), None
patent: WO 2004/046819 (2004-06-01), None
patent: WO 2004/075823 (2004-09-01), None
patent: WO 2004/085425 (2004-10-01), None
patent: WO 2004/099190 (2004-11-01), None
patent: WO 2005/023807 (2005-03-01), None
patent: WO 2005/044793 (2005-05-01), None
patent: WO 2005-053792 (2005-08-01), None
patent: WO 2005/070891 (2005-08-01), None
patent: WO 2005/070906 (2005-08-01), None
STN search report of abstract of DE 2164661, Tropitzsch, Jul. 1973.
U.S. Appl. No. 60/599,025.
Agrawal, et al., “Synthesis of 5(6)-Substituted 2-Alkyl/Arythio- & 2-Alkyl/Arysulphono-benzimidazoles as Potential Anthelmintics”, Indian J of Chemsitry, 22B, 781-784 (1983).
Huang, et al., “Liquid-Phase Combinatorial Synthesis of Aminobenzimidazoles”, Bioorganic & Medicinal Chemistry Letters, 12, 1001-1003 (2002).
Bendale, et al., “Rapid Microwave-Assisted Liquid-Phase Combinatorial Synthesis of 2-(Arylamino-benzimidazoles”, J Combinatorial Chem., 4, 359-361 (2002).
Takubo, Takao; Yakugaku Zasshi, “Syntheses of Diaryl Sulfone VIII. On iin vivo Growth Inhibiting Action of Diaryl Sulfones” 81, 1812-1816 (1961).
Dimroth, et al, Liebigs Ann. Chem. “Uber die Reaktion der Quartarsalze von 2-Chlor-Heterocyclen mit aromatischen Aminen und Phenolen”3, 380-386 (1973).
Simonov, et al., Khimiya Geterotsiklicheskikh Soedinenii, “Research on Benzimidazole. XXXVIII. Reaction of Benzimidazole-2-Sulfonic Acids with Ammonia, Amines and some Azoles”6, 826-828 (1975).
Kulkarmi, et al., Arch. Pharm, “Synthesis, Spectral Studies and Anti-Inflammatory Activity of Some New 2-Aryloxybenzimidazoles”314, 440-447 (1981).
Norman Mark H.
Ognyanov Vassil I.
Wang Xianghong
Amgen Inc.
Chu Yong
McKane Joseph
Person Richard V.
LandOfFree
Benzo[ d ]imidazol analogs as vanilloid receptor ligands and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo[ d ]imidazol analogs as vanilloid receptor ligands and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo[ d ]imidazol analogs as vanilloid receptor ligands and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3981043